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Abstract Peripherin/RDS is a member of the tetraspanin
family of integral membrane proteins and plays a major
role in the morphology of photoreceptor outer segments.
Peripherin/RDS has a long extracellular loop (hereafter
referred to as the LEL domain), which is vital for its
function. Point mutations in the LEL domain often lead to
impaired photoreceptor formation and function, making
peripherin/RDS an important drug target. Being a eukary-
otic membrane protein, acquiring sufficient peripherin/
RDS for biophysical characterisation represents a sig-
nificant challenge. Here, we describe the expression
and characterisation of peripherin/RDS in Drosophila
melangolaster Schneider (S2) insect cells and in the
methylotrophic yeast Pichia pastoris. The wild-type
peripherin/RDS and the retinitis pigmentosa causing
P216L mutant from S2 cells are characterised using
circular dichroism (CD) spectroscopy. The structure of
peripherin/RDS and of a pathogenic mutant is assessed
spectroscopically for the first time. These findings are
evaluated in relation to a three-dimensional model of the
functionally important LEL domain obtained by protein
threading.
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Abbreviations
LEL domain Long extracellular loop domain
CD Circular dichroism
p/RDS Peripherin/retinal degeneration slow
NMR Nuclear magnetic resonance
CD81 Cluster of differentiation 81
DDM n-Dodecyl beta-D-maltoside
BCA Bicinchoninic acid
LC–MS/MS Liquid chromatography-mass
spectrometry/mass spectrometry
ROM-1 Retinal outer segment membrane protein 1
FTIR Fourier transform infrared
SDS Sodium dodecyl sulfate
PAGE Polyacrylamide gel electrophoresis
Introduction
Tetraspanins are an important mammalian membrane
protein family that is involved in roles such as the
immunological response (Levy et al. 1998), sperm-egg
fusion (Hemler 2003) and vision (Molday et al. 1987).
Also, tetraspanins have been shown to be implicated in
various diseases, including cancer (Lazo 2007), hepatitis C
(Zhang et al. 2004) and retinitis pigmentosa (Shastry
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1994). Although their exact function remains elusive,
tetraspanins are known to be the key components in the
‘tetraspanin web’, protein-enriched microdomains remi-
niscent of lipid rafts [for a review, see (Hemler 2005)]. In
this web, tetraspanins are thought to act as ‘molecular
organisers’ or ‘scaffolding proteins’. Being eukaryotic
membrane proteins, obtaining sufficient quantities of tet-
raspanin protein for structural characterisation can be a
limiting factor for structural studies. The only tetraspanin
that has been characterised structurally is CD81, which was
expressed in high levels (1.75 mg/l culture) in the methy-
lotrophic yeast Pichia pastoris (Jamshad et al. 2008) and in
HEK293S-TetR-inducible cell lines (Takayama et al. 2008)
at a final concentration of*26 lg/3 9 107 cells per 15 cm
tissue culture plate. The functionally important large
extracellular loop (hereafter referred to as LEL domain) of
CD81 has been overexpressed in E. coli as a separate,
water-soluble protein, which enabled the determination
of a high-resolution X-ray structure (Kitadokoro et al.
2001).
Here, we present our recent studies on the expression
and spectroscopic characterisation of recombinant peri-
pherin/RDS (hereafter referred to as p/RDS). P/RDS is
implicated in many hereditary diseases that lead to
impaired vision, most notably autosomal dominant retinitis
pigmentosa. The majority of the pathogenic mutations are
single-point mutations in the LEL domain (see Fig. 1: the
amino acid residues in the LEL domain are indicated
explicitly with their one-letter codes). In vivo, p/RDS is
located in the outer segment of rod cells, where it is
involved in the flattening of the membrane discs (Wrigley
et al. 2000) that contain rhodopsin, the protein responsible
for the initial events in phototransduction [i.e., absorption
of a photon and initiation of the biochemical pathway that
ultimately lead to an hyperpolarisation of the rod cell outer
membrane; for a review see (Palczewski 2006)]. P/RDS
has the hallmark characteristics of a tetraspanin: i.e., four
transmembrane a-helices and an LEL domain with the Cys-
Cys-Gly motif that sets it apart from other proteins with
four transmembrane a-helices (Wrigley et al. 2002). The
main difference between p/RDS and other tetraspanins is
the size of the LEL domain, which is almost twice as long
as that of other tetraspanins such as CD81 (140 vs. 87
amino acid residues). This characteristic is of particular
interest since most pathogenic mutations are located in the
p/RDS LEL-domain.
a b
c
Fig. 1 a Schematic representation of a rod cell outer segment
containing flattened lipid vesicles. b Schematic magnification of the
rim region of the flattened vesicles containing rhodopsin (transmem-
brane helices are red cylinders, orientation taken from protein
databank file 1JGJ) and peripherin rds (transmembrane helices are
blue and white cylinders, orientation taken from protein databank file
2AVZ, a modeled structure of tetraspanin CD81). To prevent
crowding, only two p/RDS molecules in the tetrameric core complex
are shown, and the loops are not shown. c Topology model of
peripherin/RDS based on glycosylation scanning from earlier work.
TM helices 3 and 4 are indicated in blue; helices 1 and 2 are indicated
in white. The large extracellular loop 2 (LEL domain) is given as a
string of circles, with inside the one-letter abbreviation for the amino
acid residues. Mutations implicated in autosomal dominant retinitis
pigmentosa are highlighted in red; the P216L mutation is indicated
with the blue arrow
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In this paper, for the first time, we demonstrate
expression of p/RDS in quantities sufficient for spectro-
scopic characterisation. The protein is expressed in two
different expression systems, cultured insect cells (S2 cells)
and the methylotrophic yeast Pichia Pastoris. Both the
wild-type protein and the pathogenic L216P mutant
expressed in S2 cells have been characterised using SDS–
PAGE and CD spectroscopy. The results suggest that the
structural disturbance of the LEL domain due to the path-
ogenic point mutation is small. Interestingly, our CD data
suggest that the structure of the p/RDS LEL domain is
different from that of other tetraspanins at least in the
additional protein fragment, offering new insights on the
functional role of p/RDS in disk morphogenesis.
Methodology
Molecular biology
Peripherin/retinal degeneration slow cDNA was a kind gift
of Prof. Jane Farrar (Trinity College, Dublin). The p/RDS
gene was cloned into the pAC5.1-V5-HIS A expression
vector using standard molecular biology techniques (see
Fig. 2 for the resulting constructs). The P216L mutant
p/RDS was prepared with the QuikChange site-directed
mutagenesis kit using the original cDNA as a template and
cloned into the pAC5.1-V5-HIS expression vector. The
p/RDS gene was subcloned from the pAC5.1-V5-HIS A
vector into the Pichia Pastoris expression vector pPICZ A
using the Eco RI and Apa I restriction sites. The nucleotide
sequence of the final expression vectors was confirmed by
Lark technologies using automated DNA sequencing.
Protein expression and purification
Chemicals were purchased from Sigma unless specified
otherwise. S2 cells were transfected using the calcium
phosphate protocol for stable cell lines [version H (Invit-
rogen 2003)]. Cultures were expanded to a final volume of
300 ml in a *2-l spinner flask (Jencons technologies)
where they were grown to a cell density of 1–3 9 107
cells/ml. Cells were harvested and stored at -80C prior to
subsequent processing. For purification, the pooled frac-
tions were lysed on ice osmotically using 20 mM Tris, pH
7.4, in the presence of complete EDTA-free protease
inhibitor (Roche). Lysed cells were collected by centrifu-
gation at 45,000 rpm in a Beckman TL-100 ultracentrifuge
for 1 h at 4C. Membrane proteins were extracted from the
lysed cells using 1% DDM in 50 mM NaH2PO4, pH 8.0
(Gibco), in the presence of complete protease inhibitor for
1 h at room temperature with agitation. Cell debris and
insoluble protein were removed by centrifugation for 1 h at
4C at 45,000 rpm in a Beckman TL-100 ultracentrifuge.
The first purification step was carried out with pre-equili-
brated Ni–NTA superflow (Qiagen) using a disposable
column (Pierce chemicals). The second purification step
was performed using V5-antibody agarose (Abcam) pre-
equilibrated with Ni–NTA elution buffer (1% DDM,
50 mM NaH2PO4, 300 mM NaCl, 250 mM imidazole, pH
8.0). Protein was eluted from the V5 agarose by addition of
V5-antibody elution buffer (2.5 mM glycine pH 2.0);
100 ll Tris–HCl was added immediately to the 1-ml elu-
tion fractions to adjust the pH to 8.0 immediately after
elution. HRP-conjugated V5 antibody was purchased from
Invitrogen.
Pichia pastoris cells (strain KM71H) were transformed
with a PmeI linearised p/RDS pPICZ expression vector.
Transformation was performed using the lithium method
described in the Invitrogen manual [Version D (Invitrogen
1997)]; the largest colonies were selected for subsequent
analysis. Integration of the p/RDS gene into the genome
was confirmed using the PCR method described in the
manual. Stably transformed cells were spread on YPD
plates [1% yeast extract, 2% peptone (BD), 2% glucose,
2% agar] with media containing 100 lg/ml zeocin. After
3 days, cells were scraped from the YPD plates and diluted
into YP medium in the presence of 2% glycerol. Cells were
grown overnight until the absorbance at 600 nm reached
*5 the following morning. Cells were harvested by cen-
trifugation at 7,000g for 5 min at 25C and diluted by a
factor of 5 into YP medium. Methanol was added to a final
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Fig. 2 a DNA construct used for the expression of recombinant
p/RDS in S2 cells. P is the promotor for expression of the Drosophila
actin 5c, which permits high-level constitutive expression of heter-
ologous proteins. EcoR V and Xba I are the restriction sites used for
cloning the of the PCR product into the Drosophila pAc5.1/V5-His
expression vector. V5 is the V5 epitope that is used for purification
and identification of the protein. (His)6 is the hexahistidine tag that is
used in the purification of the protein. S is the stop codon on the
expression vector. b DNA construct used for the expression of
recombinant p/RDS in Pichia pastoris. P is the AOX1 promotor that
allows methanol-induced, high-level expression in P. pastoris. EcoR I
and Apa I are the restriction sites that were used to subclone the
p/RDS gene from the Drosophila expression vector into the pPICZ,
A expression vector for P. pastoris. c-myc is the c-myc epitope that
was used for identification of the protein. (His)6 is the hexahistidine
tag that was used for purification of the protein. S is the stop codon on
the expression vector
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concentration of 1%, and cells were induced for 8 h, after
which they were harvested and stored at -80 until puri-
fication. Each cell pellet (the equivalent of 50 ml of cul-
ture) was resuspended in 1 ml of lysis buffer (PBS tablets
from Gibco: 10 mM NaPO4, 150 mM NaCl, pH 7.4). An
equal volume of acid-washed glass beads (425–600 nm,
30–40-US sieve) was added to the cell suspension; cells
were lysed in a 15-ml plastic tube by 10 times 30 s vig-
orous vortexing on a IKA Genius 3 vortex at full power
with 30-s intervals, during which the cells were kept on ice.
The lysate was centrifuged for 1 min at 7,000g to remove
cell debris. Cell membranes in the supernatant were col-
lected by centrifugation at 45,000 rpm in a Beckman
TL-100 ultracentrifuge for 1 h at 4C. The supernatant was
discarded, and the cell membranes were resuspended in
PBS buffer (10 mM NaPO4, 150 mM NaCl, 1 ml per 50
ml original culture) containing 1% n-dodecyl-b-D-malto-
side (DDM) using sequentially an 18-G, 19-G, and 25-G
needle. The suspension was incubated with pre-equili-
brated Ni–NTA superflow resin (100 ll per ml, Qiagen).
The Ni–NTA superflow was washed twice with 20 mM
imidazole in PBS buffer containing 0.1% DDM, prior to
elution with 250 mM imidazole in PBS buffer containing
0.1% DDM.
Sodium dodecyl sulphate–polyacrylamide gel electro-
phoresis was performed as described in the literature
(Sambrook and Russell 2001), using the Hoefer mighty
small gel system for electrophoresis. Briefly, the resolving
gel was prepared using *7 ml of 10% acrylamide mix,
National Diagnostics, 375 mM Tris, pH 8.8 and 0.1% SDS.
Polymerisation was initiated by the addition of ammonium
persulphate and N, N, N0, N0-tetramethylethylenediamine
to final concentrations of 0.1 and 0.04%, respectively. The
stacking gel (*4 ml) consisted of 5% acrylamide mix,
127 mM Tris, pH 6.8, 0.1% SDS; polymerisation was
initiated by addition of 0.1% ammonium persulphate and
N, N, N0, N0-tetramethylethylenediamine to final concen-
trations of 0.1 and 0.01%, respectively.
For the dimerisation experiments (Fig. 3b, d), mem-
brane proteins were extracted from the lysed cells as
described above without further purification by affinity
chromatography. After removal of the cell debris and
insoluble protein, 15 ll of protein solution was mixed with
15 ll of 29 SDS gel-loading buffer (100 mM Tris–Cl, 4%
SDS, 0.2% bromophenol blue, and 20% glycerol). In the
case of reducing conditions, 1% b-mercaptoethanol was
added to the loading buffer; samples were incubated for
30 min at 37C and allowed to cool for 10 min at room
temperature prior to loading on the gel. The non-reduced
samples were loaded on the gel immediately after mixing
with loading buffer. Analysis of purified protein with SDS–
PAGE (Figs. 3a, c, 4a, b) was performed as described for
reducing conditions. Electrophoresis was performed at
100 V at room temperature for *2 h until the dye-front
reached the bottom of the gel. Silver staining was per-
formed according to the instructions provided in the
PlusOneTM silver staining kit (GE Healthcare). Coomassie
staining was performed on a shaking platform for 1 h at
room temperature using 10% glacial acetic acid, 45%
methanol, 45% distilled water and 0.25% Coomassie
Brilliant Blue R. Destaining was done using 7.5% glacial
acetic acid and 10% methanol for 24 h.
Proteins were transferred to PVDF membrane (Amer-
sham) using a transfer unit for semi-dry transfer (Cleaver
Scientific) according to the manufacturer’s instructions.
Western blots were probed with c-myc tag mouse mono-
clonal antibody (Cell Signaling), using anti-mouse HRP
conjugated antibody as the secondary (Promega). Mass
spectrometry analysis was performed on a an LC/MS
system consisting of a 1,200 Series liquid chromatograph,
an HPLC-Chip Cube MS interface and SL IT mass
spectrometer (all Agilent Technologies, USA). The
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Fig. 3 a Silver-stained SDS gel of purified p/RDS from S2 cells
using subsequently Ni–NTA superflow agarose and V5-agorose.
b Western blot of p/RDS from S2 cells in the presence 1 and in the
absence 2 of reducing agent, respectively. The blot was probed with
monoclonal anti-V5 antibody. Note that the blot was performed using
the solubilised membrane protein fraction, described in Materials and
methods, without further purification. c Coomassie blue-stained SDS
gel of purified P216L mutant from S2 cells. d p/RDS P216L mutant
from S2 cells in the presence 1 and in the absence 2 of reducing agent.
Note that the blot was performed using the solubilised membrane
protein fraction without further purification
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chromatographic chip incorporated a 40-nl enrichment
column, a 150 mm/75-lm analytical column packed with
Zorbax 300SB-C18 5-mm particles and a nanospray nee-
dle. In-gel protein digests were adapted from the protocol
by Shevchenko et al. (1996).
Circular dichroism
The CD spectrum of wild-type p/RDS and of the P216L
mutant pRDS in 10 mM Tris/HCl (pH 8.0) buffer with 1%
DDM was acquired on a Model 400 Spectrometer (Aviv
Biomedical Ltd.) using a strain-free certified 0.1 (mutant)
or 1 (wild-type) mm SUPRASIL quartz rectangular
demountable cell (Hellma UK) and as an average of 20
scans, at a scan rate of 1 s, a temperature of 20C, a scan
increment of 0.2 nm and a bandwidth of 1 nm. The spec-
trum was background corrected by subtracting the CD
spectrum of 10 mM Tris/HCl in 1% DDM acquired under
identical conditions and spectral parameters as that of the
sample. All CD spectra were acquired where the Model
400 dynode voltage was kept below 500 volts, as per
specification. The CD spectrum was analysed with the
CDSSTR (Sreerama and Woody 2000) and K2D (Andrade
et al. 1993) programs using the Dichroweb server (Whit-
more and Wallace 2004). Protein concentration was
determined by quantitative amino acid analysis (PNAC
Facility, Cambridge, UK) (wild-type protein) and by BCA
assay (wild-type protein, P216L mutant).
Molecular modelling
Pictures of the protein models were constructed using the
MOLMOL software (Koradi et al. 1996); secondary
structures assignments were carried out using the Kabsch
and Sander algorithm (Kabsch and Sander 1983). Sec-
ondary structure predictions were performed with the
Jpred3 webserver (Cole et al. 2008). Protein threading was
carried out using the TASSER software (Zhang 2008).
Results
p/RDSp expression in S2 cells
Analysis by SDS–PAGE of the purified wild-type p/RDS
and of the P216L mutant (Fig. 3a, c, respectively) shows a
single band with an apparent molecular weight (AMW) of
*37 kD consistent with the apparent molecular weight of
the monomeric protein reported in the literature (Goldberg
et al. 2001), although some dimeric species can also be
observed in the case of the mutant. The final purified
protein yield was 50 and 220 lg from *1 l of culture for
the wild-type protein and the P216L mutant, respectively.
The protein concentrations used for the CD experiments
were 50 and 220 lg/ml as determined by BCA assay.
The identity of both the wild-type p/RDS and the P216L
mutant was confirmed using Western blot probed with a
HRP-conjugated V5 antibody with both proteins running as
a single band at the appropriate size in the presence of
reducing agent (see Fig. 3b, d, respectively). In addition,
analysis by LC–MS/MS mass spectrometry of the wild-
type protein identified seven human p/RDS peptides after
in-gel digestion (MASCOT score 243, cutoff value at
P\ 0.05 was 52 in this search).
In vivo, p/RDS forms tetrameric core complexes; the
core complexes are linked by intermolecular disulphide
bridges to form higher order oligomers, a process that is
modulated by a close structural neighbour of peripherin/
RDS, ROM-1 (Goldberg et al. 2001; Loewen et al. 2001;
Loewen and Molday 2000). The formation of these core-
complex linking disulphide bridges requires proximity of
the sulphur atoms involved, which in turn requires correct
folding of the protein. Therefore, the presence of disul-
phide-bonded dimers on SDS–PAGE is an indication that
the protein is able to self-assemble and is correctly folded.
To assess the ability for self-assembly of both wild-type and
mutant P216L p/RDS, the electrophoretic mobility in the
presence and in the absence of a reducing agent was ana-
lysed using SDS–PAGE. For both the wild-type and mutant
protein, the Western blot of the reduced samples show a
strong band at 37 kDa corresponding to monomeric peri-
pherin/rds. In the absence of b-mercaptoethanol, the 70-kDa
band corresponding to the dimeric species is the prominent
species for both proteins (Fig. 3b, d, upper arrow). Fur-
thermore, under non-reducing conditions, the monomer
displays an increase in electrophoretic mobility relative to
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Fig. 4 a Silver-stained SDS gel of p/RDS from Pichia pastoris
purified with Ni–NTA superflow agarose. b Western blot of p/RDS
from P. pastoris purified with Ni–NTA superflow agarose. The blot
was probed with monoclonal anti-c-myc antibody. Note that the
purity in the case is less due to non-specific binding of yeast proteins
to Ni–NTA superflow agarose
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the monomer in the presence of b-mercaptoethanol under
reducing conditions (Fig. 3d, b, lower arrow). The same
pattern is observed for the P216L mutant, with the band
corresponding to the monomer running at a slightly lower
apparent molecular weight in the absence of reducing agent.
p/RDSp expression in Pichia pastoris
Analysis by SDS–PAGE of the purified wild-type p/RDS
expressed in Pichia pastoris shows multiple bands after
staining, with two bands (Fig. 4) corresponding to apparent
molecular weights of*37 and*40 kD being the dominant
species. The apparent molecular weight of 37 kD is con-
sistent with the apparent molecular weight of the monomer
reported in the literature (Wrigley et al. 2002). The same
two bands are present upon analysis with Western blot at
apparent molecular weights of *37 and *40 kD.
Structural characterisation of wild-type and mutant
P216L p/RDS from S2 cells
Circular dichroism (CD) spectroscopy was used to char-
acterise the secondary structure of p/RDSp in n-dodecyl-b-
D-maltoside (DDM). P/RDSp shows bands at*208 and at
*222 nm, indicative of a-helical structure (Fig. 5a). The
intensity of the CD spectrum of the P216L mutant is
slightly increased as compared to that of the wild type. The
shape of the P216L mutant is similar to that of the
wild-type protein (Fig. 5b, c), with bands at *208 and
*222 nm indicating the presence of significant a-helical
structure. Further comments are included in the discussion.
Discussion
Expression of recombinant peripherin/RDS in S2 cells
and in Pichia pastoris
Our results clearly demonstrate the expression of both the
wild-type and the mutant protein in S2 cells, and expres-
sion of the wild-type protein in the methylotrophic yeast
Pichia pastoris. Expression levels in S2 cells are sufficient
for a structural characterisation with circular dichroism
spectroscopy (total yield of *50 lg/l culture for the wild
type and *220 lg/l culture for the mutant protein).
However, in order to perform high-resolution structural
determination using NMR or X-ray crystallography, and
also for alternative techniques of secondary structure
Fig. 5 a CD spectra of wild-
type p/RDS (red) and of the
P216L mutant (blue). The wild
type was measured in a 1-mm
cuvette, the mutant in a 0.1-mm
cuvette. b Same spectra as (a),
but normalised to the same
intensity. c Both proteins
measured in 1-mm cuvette.
Note that the spectrum of the
wild-type protein could not be
collected for wavelengths below
200 nm due to a decreased
concentration
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determination such as FTIR-spectroscopy, larger protein
quantities are required than those obtained here. When
scaling up the production of recombinant protein in cul-
tured insect cells, the cost effectiveness of this system
should be considered, since the procedure for growing
insect cells in tissue culture is labour intensive, and the
chemicals are expensive compared to those required for
protein expression in bacteria and yeast. For this reason,
the demonstrated expression of p/RDS in Pichia pastoris is
a significant advance. Preliminary data from experiments in
small-scale bioreactors indicate expression levels of
*0.3 mg/l, which is comparable to the per liter expression
of the protein in S2 cells. This protein could be purified to
the same degree as the protein from S2 cells using
sequentially Ni–NTA and cmyc agarose. Using optimised
protocols for culturing the yeast, we believe that the protein
expression can be increased even further.
Self-assembly of wild-type and P216L mutant
peripherin/RDS from S2 cells
The presence of a single band for both the purified wild-
type p/RDS and for the P216L mutant shows that pure
protein was obtained after the two-step purification
approach using sequentially Ni–NTA superflow and V5
agarose. No bands are observed at higher molecular
weight, indicating that the protein does not form non-spe-
cific aggregates when exposed to the reducing conditions
used for SDS–PAGE. The Western blot of both wild-type
and mutant peripherin/RDS in the presence of reducing
agent shows a single band at the apparent molecular weight
of the protein, although some higher molecular weight
species are also observed in the case of the mutant protein.
However, it is clear that in the absence of reducing agent
for both wild-type and mutant, the relative amount of dimer
is much increased.
Furthermore, in the absence of reducing agent, the
apparent molecular weight of both the monomeric mutant
and the wild-type protein decreases slightly, which could
suggest a more compact structure of the monomer. Possibly,
in the absence of reducing agent some disulphide bridges
remain intact, resulting in retention of residual structure in
the presence of SDS. Also, for both wild-type and mutant
protein, the dimer is the dominant species, highlighting the
capacity of both wild-type and P216L mutant protein to
self-assemble. Although SDS–PAGE can give rise to non-
specific aggregation, the formation of specific dimers is
well documented for p/RDS [see, for instance, (Loewen and
Molday 2000)]. Therefore, our observations suggest that
both the wild-type and the mutant protein are correctly
folded, and that the P216L mutation has no strong disrup-
tive effect on the structure of the LEL domain.
Expression of p/RDS in Pichia pastoris
The silver-stained gel after single-step purification with
Ni–NTA resin shows a number of non-specific protein
bands, indicating binding of protein other than hexahisti-
dine-tagged p/RDS. Non-specific protein binding to nickel
affinity chromatography is a common problem for recom-
binant protein expressed in eukaryotes as compared to
prokaryotes since the fraction of histidine-rich proteins is
higher, and the total number of proteins is larger.
TheWestern blot of p/RDS from Pichia Pastoris shows a
band at an apparent molecular weight of *37 kD. The
second band at *40 kD could be indicative of extra gly-
cosylation, which has been observed before for recombinant
glycoproteins expressed in Pichia Pastoris [(Ruitenberg
et al. 2001)]. Interestingly, also when p/RDS is expressed in
COS cells, it migrates as a doublet on SDS–PAGE, which
was ascribed to the presence of both glycosylated and non-
glycosylated forms (Muller-Weeks et al. 2002), suggesting
that also in the present study at least part of the protein
expressed in Pichia is glycosylated.
Implications of the CD experiments
The CD experiments presented here allow for a direct
assessment of the effect of a pathogenic point mutation on
the secondary structure of peripherin/RDS. Comparison of
the shape of the CD spectra (Fig. 5a) suggests that the
secondary structure of the pathogenic P216L mutant is
similar to that of the wild-type protein. To illustrate this,
the spectra were normalised to the same intensity and
superimposed in Fig. 5b. Clearly the shape of the spectra is
almost identical for wavelengths between 200 and 250 nm,
indicating that the structure of the mutant is similar to that
of the wild-type protein. This is further illustrated in
Fig. 5c, which shows the CD spectra of the wild type and
the mutant measured in the same cuvette. To further
examine this idea, a secondary structure analysis was used
to calculate the fraction of a-helix and b-sheet in both
mutant and wild-type protein. Table 1 shows that the
fraction of a-helix is increased for the mutant, whereas the
fraction of b-sheet is similar. However, since the shape of
the CD spectra is similar, these differences arise from small
differences in intensity of the spectrum that can strongly
influence the outcome of a secondary structure calculation
based on CD data. It is well documented that the magnitude
of the spectrum is affected by uncertainties in protein
concentration and in cuvette path length (McPhie 2008).
Most likely, in the present study, such factors also affected
the outcome of the secondary structure analysis. Therefore,
we conclude that the effect of the pathogenic mutation on
the secondary structure is small based on the similarity in
spectral shape and on the similar biochemical behaviour of
Eur Biophys J (2010) 39:679–688 685
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the mutant to the wild-type protein upon analysis with
SDS–PAGE.
Although it has been shown that the P216L mutation
causes photoreceptor degeneration, it is properly trafficked
to the outer segment (Loewen et al. 2003). From previous
studies it is known that an additional glycosylation site is
created by this mutation (Wrigley et al. 2002), and it was
suggested that the attachment of two bulky carbohydrate
chains to the protein may result in an altered conformation
in the protein. The SDS–PAGE analysis presented here
indicates that the glycosylation status of wild-type p/RDS
and the P216L mutant expressed in S2 cells is the same;
therefore, it is not possible to completely test this
hypothesis. However, the results presented here show that
the secondary structure is largely unaffected by the P216L
mutation. Possibly, the fold of the LEL-domain (i.e., the
arrangement of the secondary structure elements) is influ-
enced by the mutation instead, an effect that could be
further exacerbated by differences in glycosylation status
for this particular mutant (Wrigley 2002, p. 288).
We note, however, that previous studies have shown that
the insertion of a FLAG-epitope cassette between residues
I227 and T228, close to the P216, results in a change in
sedimentation behaviour indicating a disruption in subunit
assembly without impairing protein folding, whereas inser-
tion of the same FLAG epitope at most other sites did not
influence its sedimentation profile (Goldberg et al. 2001).
Towards a three-dimensional structure of the LEL
domain
To fully evaluate the implications of our CD data, we
compared the fractions of secondary structure of wild-type
p/RDS to the topology model from our earlier work
(Wrigley et al. 2002). Neither the V5 epitope nor the
hexahistidine tag is expected to contribute secondary
structure (Li et al. 2006; Narayana et al. 1997). Also, since
both tags are located at the intrinsically disordered C-ter-
minal domain (Edrington et al. 2007), they are not expected
to interfere with the structure or function of p/RDS.
The CD secondary structure analysis shows that the
fraction of a-helix is 0.29–0.57, the equivalent of 109–215
amino acid residues. The a-helical residues are mostly
accounted for by the four transmembrane helices that
together make up *81 a-helical residues. For the tetra-
spanin CD81 it has been shown that the LEL domain is
predominantly a-helical (Kitadokoro et al. 2001). Based on
homology to the LEL domain of tetraspanin CD81, it is
likely that for peripherin/RDS, a large portion of the non-
transmembrane a-helical residues is located in this LEL-
domain. Also, part of the observed b-sheet structure is
probably located in the LEL domain.
For comparison, a structure prediction of the p/RDS
LEL domain was performed using Jpred 3 software (Cole
et al. 2008; Fig. 6) for secondary structure prediction and
using the computer program TASSER (Threading
ASSEmbly Refinement) (Zhang and Skolnick 2004) for
three-dimensional structure prediction. Jpred 3 predicts
with high confidence the a-helix between amino acid res-
idues 123–138 (conserved tetraspanin helix A, Seigneuret
2006), between residues 151–162 (helix B) and between
residues 251–259 (helix E) with patches of a-helix and
b-sheet in the region between.
Two three-dimensional models, depicted in Fig. 7 (left
and middle panel), are returned by the TASSER threading
software with a TM score greater than threshold (the TM
scores for these models are 0.73 and 0.58, respectively: a
TM score[0.5 indicates a model of correct topology and a
TM score \0.17 means random similarity, Zhang and
Skolnick 2004). For comparison, the structure of the CD81
LEL domain is also depicted in Fig. 7 (right panel).
Although the three-dimensional structure of the two
TASSER models is different, the secondary structure lar-
gely overlaps, with a-helices A, B and E present in
approximately the same places as for the 2D model. The
main differences with the 2D model is that the b-sheet
content is zero, and the fraction of a-helix is increased. In
summary, our findings from the CD experiments, which
suggest the presence of a b-sheet in the p/RDS variable
region, are qualitatively in better agreement with the
Table 1 Percentages of a-helix, b-sheet and coil for the wild-type protein and for the P216L mutant
Protein Type of cuvette
used (mm)
Algorithm
used/dataset
(if applicable)
Fraction a-helix/nr
of residues
in a-helix
Fraction b-sheet/nr
of residues
in b-sheet
Fraction coil/nr
residues in coil/
unordered
NRSMD
p/RDS, wild type 1 K2D/NA 0.29/109 0.16/60 0.54/208 0.069
p/RDS, P216L mutant 1 K2D/NA 0.55/207 0.13/49 0.33/121 0.105
p/RDS, P216L mutant 0.1 K2D/NA 0.57/215 0.08/30 0.35/132 0.039
p/RDS, P216L mutant 0.1 CDSSTR/SP175 0.48/181 0.10/38 0.42/158 0.141
Note that the fractions of turn and unordered were summed up to give the fraction of coil in the case of the CDSSTR analysis. The upper two
rows are the results from the K2D analysis in 1-mm cuvette; the two bottom rows are results from the analysis done on data measured in the
0.1 mm cuvette
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secondary structure predictions, which show patches of
b-sheet in the LEL domain, than with the TASSER models,
which show a mixture of a-helix and coil, possibly because
the TASSER software tries to accommodate the model to
the only known three-dimensional tetraspanin structure.
Quantitatively, our CD data suggest that the amount of
b-sheet is even greater than indicated by the secondary
structure predictions, which show only *7 residues in a
b-sheet conformation in the LEL domain.
Concluding remarks
We have demonstrated expression of peripherin/RDS in
both S2 cells and in the methylotrophic yeast Pichia
Pastoris. P/RDS from S2 cells was further characterised,
and the effect of the pathogenic P216L mutation was
evaluated. The structural effect of the pathogenic mutation
is small, indicating that the mutation might have an indirect
effect, without disturbing its secondary structure. The main
implication of our CD experiments is the presence of an
unexpected fraction of b-sheet, which is tentatively
assigned to the variable region of the LEL domain. We are
currently expressing the LEL domain as a separate soluble
protein in order to confirm the presence of a b-sheet in this
domain and to assess its functionality.
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Fig. 6 Secondary structure
prediction using JPRED3
software for the p/RDS LEL
domain. Helices are indicated as
purple cylinders; b-sheet is
indicated as yellow arrows. The
number above the amino acid
sequence indicates the position
of the residue in p/RDS; the
number below indicates the
confidence. Cystein residues are
highlighted in yellow;
hydrophobic residues are
indicated by squares. The
proline residues at position 216
are highlighted with a blue
circle
R123
F113
R123
P216
P216
Fig. 7 Left and middle panel: best scoring models (TM values are
0.73 and 0.58, respectively) of the p/RDS LEL domain calculated
using the I-TASSER software for structure prediction. Right panel:
tetraspanin CD81. Helices are represented as coloured ribbons.
Conserved tetraspanin helices A, B and E are depicted in green, red
and blue, respectively. Helices in the tetraspanin variable domain are
indicated in white. Coil domains are represented as grey tubes. The N-
terminal residue (R123 for p/RDS, F113 for CD81) is indicated with
an arrow. The proline residue at position 216 is indicated in blue
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